RXULTI Trademark

Trademark Overview


On Tuesday, July 31, 2018, a trademark application was filed for RXULTI with the United States Patent and Trademark Office. The USPTO has given the RXULTI trademark a serial number of 88060109. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 28, 2022. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The RXULTI trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, cancer, migraine, pain, alcoholism and dependency; di...
rxulti

General Information


Serial Number88060109
Word MarkRXULTI
Filing DateTuesday, July 31, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 28, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 27, 2018

Trademark Statements


Goods and ServicesVaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, cancer, migraine, pain, alcoholism and dependency; diagnostic agents, reagents, preparations and substances for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 7, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChiyoda-ku, Tokyo 101-8535
JP

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChiyoda-ku, Tokyo
JP

Trademark Events


Event DateEvent Description
Monday, February 28, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 28, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 2, 2021EXTENSION 5 GRANTED
Tuesday, May 18, 2021EXTENSION 5 FILED
Tuesday, May 25, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 18, 2021TEAS EXTENSION RECEIVED
Wednesday, December 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 7, 2020EXTENSION 4 GRANTED
Monday, December 7, 2020EXTENSION 4 FILED
Monday, December 7, 2020TEAS EXTENSION RECEIVED
Saturday, July 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 2, 2020EXTENSION 3 GRANTED
Thursday, July 2, 2020EXTENSION 3 FILED
Thursday, July 2, 2020TEAS EXTENSION RECEIVED
Saturday, January 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 16, 2020EXTENSION 2 GRANTED
Thursday, January 16, 2020EXTENSION 2 FILED
Thursday, January 16, 2020TEAS EXTENSION RECEIVED
Wednesday, April 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 22, 2019EXTENSION 1 GRANTED
Monday, April 22, 2019EXTENSION 1 FILED
Monday, April 22, 2019TEAS EXTENSION RECEIVED
Tuesday, January 22, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 27, 2018PUBLISHED FOR OPPOSITION
Wednesday, November 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 16, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 15, 2018ASSIGNED TO EXAMINER
Wednesday, September 5, 2018PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, August 28, 2018ASSIGNED TO LIE
Thursday, August 9, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, August 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 3, 2018NEW APPLICATION ENTERED IN TRAM